Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia:: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique

被引:140
作者
Avet-Loiseau, H
Daviet, A
Brigaudeau, C
Callet-Bauchu, E
Terré, C
Lafage-Pochitaloff, M
Désangles, F
Ramond, S
Talmant, P
Bataille, R
机构
[1] Univ Hosp, Hematol Lab, Nantes, France
[2] Univ Hosp, Hematol Lab, Limoges, France
[3] Hop Lyon Sud, Hematol Lab, Pierre Benite, France
[4] Gen Hosp, Lab Cytogenet, Versailles, France
[5] Inst J Paoli I Calmettes, Lab Cytogenet, F-13009 Marseille, France
[6] Hosp Val de Grace, Lab Cytogenet, Paris, France
[7] Hotel Dieu, Hematol Lab, Paris, France
关键词
D O I
10.1182/blood.V97.3.822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary plasma cell leukemia (PCL) is a rare plasma cell malignancy. Consequently, few large reports have been published, Presented is a cytogenetic analysis of 40 patients with primary PCL compared with 247 newly diagnosed patients with stage III multiple myeloma (MM), Cytogenetic abnormalities were observed in 23 of 34 patients, with usually complex hypodiploid or pseudodiploid karyotypes, Analysis of rearrangements of the 14q32 region revealed significant differences with high cell mass MM-a higher incidence of t(11;14) (33% vs 16%; P<.025) and of t(14;16) (13% vs 1%; P<.002) though incidences of t(4;14) were identical and a higher incidence of monosomy 13 (68% vs 42%; P=.005), Hypodiploid karyotypes and monosomy 13 may explain, at least in part, the poorer prognosis of primary PCL, In contrast, significantly longer survival was observed in patients displaying t(11;14) in comparison with those lacking this translocation (P=.001), (C) 2001 by The American Society of Hematology.
引用
收藏
页码:822 / 825
页数:4
相关论文
共 22 条
[1]  
Avet-Loiseau H, 1999, CANCER RES, V59, P4546
[2]   Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma [J].
Avet-Loiseau, H ;
Li, JY ;
Morineau, N ;
Facon, T ;
Brigaudeau, C ;
Harousseau, JL ;
Grosbois, B ;
Bataille, R .
BLOOD, 1999, 94 (08) :2583-2589
[3]  
Avet-Loiseau H, 1998, CANCER RES, V58, P5640
[4]   Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma [J].
Bergsagel, PL ;
Chesi, M ;
Nardini, E ;
Brents, LA ;
Kirby, SL ;
Kuehl, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13931-13936
[5]   Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma [J].
Chesi, M ;
Bergsagel, PL ;
Shonukan, OO ;
Martelli, ML ;
Brents, LA ;
Chen, T ;
Schröck, E ;
Ried, T ;
Kuehl, VM .
BLOOD, 1998, 91 (12) :4457-4463
[6]  
Desikan R, 2000, BLOOD, V95, P4008
[7]   PRIMARY PLASMA-CELL LEUKEMIA [J].
DIMOPOULOS, MA ;
PALUMBO, A ;
DELASALLE, KB ;
ALEXANIAN, R .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) :754-759
[8]   Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases [J].
Fonseca, R ;
Witzig, TE ;
Gertz, MA ;
Kyle, RA ;
Hoyer, JD ;
Jalal, SM ;
Greipp, PR .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (02) :296-301
[9]   Primary plasma cell leukemia:: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics [J].
García-Sanz, R ;
Orfao, A ;
González, M ;
Tabernero, MD ;
Bladé, J ;
Moro, MJ ;
Fernández-Calvo, J ;
Sanz, MA ;
Pérez-Simón, JA ;
Rasillo, A ;
San Miguel, JF .
BLOOD, 1999, 93 (03) :1032-1037
[10]  
JONVEAUX P, 1992, GENE CHROMOSOME CANC, V4, P231